Literature DB >> 23279646

Naltrexone does not affect isoflurane minimum alveolar concentration in cats.

Robert J Brosnan1, Bruno H Pypendop, Chalon R Majewski-Tiedeken, Yael Shilo-Benjamini, Jan E Ilkiw.   

Abstract

OBJECTIVE: To test whether naltrexone, an opioid receptor antagonist, affects the minimum alveolar concentration (MAC) of isoflurane in cats, a species that is relatively resistant to the general anesthetic sparing effects of most opioids. STUDY
DESIGN: Randomized, crossover, placebo-controlled, blinded experimental design. ANIMALS: Six healthy adult cats weighing 4.9 ± 0.7 kg.
METHODS: The cats were studied twice. In the first study, baseline isoflurane MAC was measured in duplicate. The drug (saline control or 0.6 mg kg(-1) naltrexone) was administered IV every 40-60 minutes, and isoflurane MAC was re-measured. In the second study, cats received the second drug treatment using identical methods 2 weeks later.
RESULTS: Isoflurane MAC was 2.03 ± 0.12% and was unchanged from baseline following saline or naltrexone administration. CONCLUSION AND CLINICAL RELEVANCE: Minimum alveolar concentration was unaffected by naltrexone. Because MAC in cats is unaffected by at least some mu-opioid agonists and antagonists, spinal neurons that are directly modulated by mu-opioid receptors in this species cannot be the neuroanatomic sites responsible for immobility from inhaled anesthetics.
© 2012 The Authors. Veterinary Anaesthesia and Analgesia © 2012 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesiologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279646      PMCID: PMC3573213          DOI: 10.1111/vaa.12004

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  11 in total

1.  Spinal motor actions of the μ-opioid receptor agonist DAMGO in the cat.

Authors:  Heinz Steffens; Eike D Schomburg
Journal:  Neurosci Res       Date:  2011-01-27       Impact factor: 3.304

2.  Naloxone does not increase the minimum alveolar anesthetic concentration of sevoflurane in mice.

Authors:  Mark Liao; Michael J Laster; Edmond I Eger; Michael Tang; James M Sonner
Journal:  Anesth Analg       Date:  2006-05       Impact factor: 5.108

Review 3.  Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration.

Authors:  James M Sonner; Joseph F Antognini; Robert C Dutton; Pamela Flood; Andrew T Gray; R Adron Harris; Gregg E Homanics; Joan Kendig; Beverley Orser; Douglas E Raines; Ira J Rampil; James Trudell; Bryce Vissel; Edmond I Eger
Journal:  Anesth Analg       Date:  2003-09       Impact factor: 5.108

4.  Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.

Authors:  N L Pace; K C Wong
Journal:  Anesth Analg       Date:  1979 Jan-Feb       Impact factor: 5.108

5.  Use of naltrexone to antagonize high doses of remifentanil in cats: a dose-finding study.

Authors:  Bruno H Pypendop; Robert J Brosnan; Jan E Ilkiw
Journal:  Vet Anaesth Analg       Date:  2011-11       Impact factor: 1.648

6.  Minimum alveolar anesthetic concentration: a standard of anesthetic potency.

Authors:  E I Eger; L J Saidman; B Brandstater
Journal:  Anesthesiology       Date:  1965 Nov-Dec       Impact factor: 7.892

7.  Effects of morphine, butorphanol, buprenorphine, and U50488H on the minimum alveolar concentration of isoflurane in cats.

Authors:  Jan E Ilkiw; Peter J Pascoe; Linda D Tripp
Journal:  Am J Vet Res       Date:  2002-08       Impact factor: 1.156

8.  Effects of remifentanil on measures of anesthetic immobility and analgesia in cats.

Authors:  Robert J Brosnan; Bruno H Pypendop; Kristine T Siao; Scott D Stanley
Journal:  Am J Vet Res       Date:  2009-09       Impact factor: 1.156

9.  Naloxone does not antagonize general anesthesia in the rat.

Authors:  M H Harper; P M Winter; B H Johnson; E I Eger
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

10.  Anesthetic potency of remifentanil in dogs.

Authors:  L G Michelsen; M Salmenperä; C C Hug; F Szlam; D VanderMeer
Journal:  Anesthesiology       Date:  1996-04       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.